This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Insider Trading Alert - MAR, PFE And XEC Traded By Insiders

Pfizer (PFE) - FREE Research Report

Susman Sally who is Executive Vice President at Pfizer sold 67,585 shares at $32.59 on March 5, 2014. Following this transaction, the Executive Vice President owned 173,637 shares meaning that the stake was reduced by 28.02% with the 67,585-share transaction.

Dolsten Mikael who is President R&D at Pfizer sold 35,789 shares at $32.58 on March 5, 2014. Following this transaction, the President R&D owned 344,571 shares meaning that the stake was reduced by 9.41% with the 35,789-share transaction.

The shares most recently traded at $32.43, down $0.15, or 0.46% since the insider transaction. Historical insider transactions for Pfizer go as follows:

  • 4-Week # shares sold: 160,000
  • 12-Week # shares sold: 160,000
  • 24-Week # shares sold: 170,000

The average volume for Pfizer has been 26.6 million shares per day over the past 30 days. Pfizer has a market cap of $208.7 billion and is part of the health care sector and drugs industry. Shares are up 6.73% year-to-date as of the close of trading on Wednesday.

Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. The stock currently has a dividend yield of 3.18%. The company has a P/E ratio of 19.8. Currently there are 8 analysts that rate Pfizer a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PFE - FREE

TheStreet Quant Ratings rates Pfizer as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, impressive record of earnings per share growth and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Pfizer Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
Submit an article to us!


DOW 17,678.23 -40.31 -0.23%
S&P 500 2,056.15 -4.90 -0.24%
NASDAQ 4,863.3620 -13.1570 -0.27%

Partners Compare Online Brokers

Top Rated Stocks Top Rated Funds Top Rated ETFs